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Abstract Investigation of the involvement of extracellular 
vesicles (EVs) in parasite biology has burgeoned in recent 
years. Human infecting protozoan parasites, such as 
Trypanosoma cruzi, Lesihmania sp. and Trichomonas 
vaginalis, have all demonstrated the utilization of EVs as 
virulence factors in order to activate or hamper host 
immunity. Novel findings have provided evidence that 
the deployment of EVs by Plasmodium sp. has a major 
impact in disease outcomes and serves as an integral part 
in controlling stage switching in its life cycle. Clinical 
studies have highlighted elevated levels of EVs in 
patients with severe malaria disease and EVs have been 
linked to increased sequestration of infected red blood 
cells to the endothelium, causing obstruction of blood 
flow. It has also been found that EVs produced during 
malaria disease activate innate immunity. Intriguingly, 
recent discoveries indicate that Plasmodium sp. “highjack” 
the erythrocyte microvesiculation system in order to 
cross-communicate. Both the transfer of DNA and 
parasite density regulation has been suggested as key 
mechanisms of EVs in malaria biology.  
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'Quorum sensing' refers to the regulation of gene 
expression in an organism as a response to variations in 
cell density in a population of cells. This phenomenon has 
been well studied in bacteria where certain species 
produce and secrete molecules called auto-inducers. The 
concentration of these molecules increases with increased 
cell density, while differential gene expression in a cell 
occurs once a minimal threshold stimulatory 
concentration has been reached [1]. More recently, it has 
been found that similar phenomena occur among disease- 
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causing protozoan parasites such as Leishmania sp., which 
causes leishmaniasis, Trypanosoma cruzi, the causative 
agent of Chagas disease, Trichomonas vaginalis, which 
induces vaginitis and Plasmodium sp., the malefactor of 
malaria disease. Malaria currently affects upwards of half 
a billion people each year and mortality rates have been 
estimated to exceed 600,000. The majority of deaths occur 
in the sub-Saharan regions of Africa, where young 
children, pregnant women and the elderly are at elevated 
risk of morbidity and mortality. Several species of 
Plasmodium can infect humans, namely P. ovale, P.
malariae, P. knowlesi, P. vivax and P. falciparum, where the 
latter accounts for the majority of deaths. Malaria disease 
includes symptoms such as fever and headaches, which 
in approximately 1% of P. falciparum infections can 
progress to severe cases and ultimately result in coma 
and death. The most common form of severe malaria is 
anaemia, but cerebral malaria, which comprises 
neurological disorder, is among the deadliest [2].  
 
Plasmodium species are obligate intracellular protozoan 
parasites that belong to the phylum Apicomplexa. The 
complex life cycle of the human infecting Plasmodium 
species entails switching between a mosquito vector and 
a primate host. In the host, the majority of parasites 
reproduce asexually; this stage gives rise to the severe 
symptoms and the mortality of the disease. However, 
differentiation into gametocytes (the sexual stage) also 
occurs inside the human host (Figure 1). 
Gametocytogenesis is the destiny of a minority of the 
total parasite population and the mechanisms underlying 
sexual differentiation are largely unknown. The 
gametocyte is the sole causative agent of transmission 
from the human to the mosquito, as this is the life cycle 
stage that is actively transmitted during a mosquito blood 
meal. In the mosquito midgut, male and female 
gametocytes reproduce sexually through meiosis, giving 
rise to millions of sporozoites ready to infect new human 
hosts upon subsequent mosquito feedings. Several factors 
are hypothesized for controlling the rate of malarial 
sexual stage commitment. These include host immunity, 
chemotherapeutical agents and anaemia [3], however, the 
exact mechanisms remain largely unknown [4]. It has 
been proposed that unidentified factors secreted or 
released by parasites trigger differentiation to 
gametocytes [5]. Recently however, extracellular vesicles 
(EVs) derived from iRBCs have been proposed to be a key 
factor in the regulation of sexual stage commitment.  
 
EVs are small vesicles derived from intact cells. Different 
types of vesicles have been described and are named 
according to their origin and size, such as exosomes, 
microvesicles, apoptotic bodies and oncosomes [6]. 
Exosomes, which are a type of EVs, originate from late 
endosomes and are formed in multi-vesicular bodies 
(MVB). Once the MVB fuse with the cell membrane, the 
exosomes are released in the extracellular space. 
Although exosomes were first described in reticulocytes 
in 1987 by Johnstone and colleagues, they can be secreted 
by a large variety of cells, in particular, upon cell 
activation [7]. There are currently several markers used to 
identify exosomes, such as Alix, TSG101, heat shock 
proteins and the tetraspanins (CD9, CD63 and CD81) [8,9]. 
Exosomes mediate cell to cell transfer of information 
[10,11] and regulate the immune response during 
infections and tumourogenesis [12]. Microvesicles (MVs) 
(syn. Ectosomes, microparticles) are secreted after 
budding or shedding from the plasma membrane [6] and 
they display similar physiological features as the cells 
from which they originate. For example, MVs express 
receptors from the cell of origin on their surface, allowing 
their identification by antibody labelling in complex 
biological samples [13,14]. Although it is not always 
possible to distinguish between exosomes and MVs, MVs 
are generally larger in size (0.1 - 1 μM), whereas exosomes 
range from 50-150 nm. In several published works, it is 
impossible to clearly distinguish between exosomes and 
MVs; thus, we will use the abbreviation EV as a general 
term for both types of vesicles. In this review, we discuss 
the involvement of EVs in malaria pathology and disease, 
as well as the recent discoveries of EVs as quorum sensing-
like auto-inducers of parasite density regulation, including 
their suggested functional mechanisms. 
 
 
Figure 1. Parasite life-cycle and pathogenesis: the blood stage is 
responsible for the pathology and symptoms observed in malaria 
infection. Within the 48 hours of the life cycle, the parasite 
develops into the RBC from a ring form to trophozoites and 
finally schizonts; after rupture of the iRBCs, the merozoites 
invade uninfected RBCs to repeat a new cycle. During the 
asexual cycle iRBC produce EVs that interact with immune cells 
and mediate stage conversion to gametocytes. Mature stages of 
parasites sequester in tissues to avoid clearance by the spleen, 
triggering local inflammation and activation of the endothelium 
and accumulation of immune cells, particularly in the brain. 
Vascular cells release EVs, contributing to the pathology.  
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2. Extracellular vesicles are elevated in the plasma  
of malaria patients 
 
EVs can be detected in the different body fluids of 
healthy donors such as urine [15], plasma [16], breast 
milk [17] and saliva [18]. Circulating EVs are mostly 
derived from platelets, but RBCs, blood leukocytes and 
endothelial cells are also an important source of EVs. EV 
production is elevated in several diseases, such as cancer 
[19], inflammation [20], cardiovascular disease [21], 
idiopathic thrombocytopenic purpura [22], thalassaemia 
[23] [14] in human immunodeficiency virus (HIV) 
patients [24] and Ebola Virus-infected macaques [25]. 
Thus, EVs are promising biomarkers for the diagnosis of 
pathologies, as well as in monitoring treatment response 
in patients. Furthermore, EVs are important mediators 
and regulators of physiological responses. They 
contribute to coagulation, inflammation, vascular 
homeostasis and the development of tumours and 
metastases [26]. Several studies have highlighted elevated 
levels of EVs during malaria episodes, especially in 
patients experiencing a severe form of the disease. In a 
study performed in Malawi with children aged six 
months to 12 years infected with P. falciparum, the 
plasmatic concentration of EVs-derived from endothelial 
cells was increased at the time of admission in patients 
with fatal malaria, as measured with the endothelial cell-
specific marker CD51 by flow cytometry [27], whereas in 
uncomplicated cases, the level of EVs remained at the 
same level as in healthy controls. The EV release may be 
the result of endothelium activation or a direct 
mechanical result of cytoadherence of iRBC to the 
endothelium [28]. It has been shown that activation of the 
endothelial cells by TNF-alpha in lupus leads to the 
production of EVs [29]. Similarly to lupus, plasma TNF 
concentration is increased in patients with malaria [30] 
and TNF can induce the release of procoagulant and 
proadhesive EVs from cultured cells in vitro [29]. 
Therefore, TNF is likely to play a role in local 
inflammation and the release of endothelial EVs. While 
the endothelium in the capillaries is activated, it interacts 
with leukocytes, platelets and iRBCs; therefore, other cell 
types are likely to produce EVs during malaria. A study 
performed in Douala, Cameroon, found that platelet, RBC, 
endothelial and leukocytic EV levels were elevated and to 
a lesser extent lymphocyte EVs in malaria infected 
patients with cerebral dysfunctions; however, these had 
returned to normal at the time of discharge. Interestingly, 
EV levels were found to correlate with a number of 
clinical and biological parameters. In CM patients, the 
platelet-EV increase was associated with the depth and 
duration of the coma, as indicated by the negative 
correlations between EV levels and Coma Resolution 
Time (CRT). Thus, platelet-EVs have the potential to be 
implemented as candidate markers for follow up 
diagnosis of patients post treatment, a topic of 
tremendous clinical importance.  
While the microvascular sequestration primarily involves 
iRBCs, there was no correlation between parasitaemia 
and RBC-EVs CD235a [31]. Another study composed of 
36 patients suffering from acute P. falciparum, P. vivax or P.
malariae infection based in Thailand, found that patients 
with P. falciparum had the highest concentration of RBC-
derived EVs compared to healthy controls. In this study, 
a specific marker for phospholipid PS (annexin V) and 
anti-glycophorin A were used for the identification of 
RBC EVs. In vitro, the EVs were released mostly by 
mature stage parasites. Infected RBCs release 10-15 times 
more EVs than uninfected. About 40% of the EVs were 
positive for RESA, a parasite protein, which is exported 
by the parasite to the RBC cell membrane [32]. The 
concentration of RBC-derived EVs quickly decreases after 
treatment with standard courses of artemisinin 
derivatives. EVs are likely to be removed by the spleen, 
since splenectomised malaria patients have increased 
levels and prolonged circulation of EVs [23]. The splenic 
reticular-endothelial system removes cells and particles 
that express PS on their surface. The liver and the lungs 
can also contribute to the clearance of EVs, as has been 
shown in a murine model [33]. Furthermore, it has been 
found that the concentration of EVs was elevated in P.
vivax and P. malariae infection, although to a lesser extent 
than in P. falciparum infection [34]. In a fourth study based 
in Brazil, the EVs derived from RBC (CD235a), CD45 
(leukocytes), CD41a (platelets), CD144 (endothelial cells) 
and CD41 (monocytes) [35] were analysed. The study was 
composed of 37 P. vivax malaria patients between 15-66 
years of age, 15 healthy donors and 12 ovarian cancer 
patients (an EV-inducing disease) [36]. The study 
concluded that most EVs found in plasma during P. vivax 
infections are derived from platelets, RBCs and 
leukocytes. Platelet-derived EVs increased in a linear 
fashion, with the presence of fever at the time of blood 
collection [35]. The conclusion of these studies are 
somewhat varied and it is important to note that the 
number of patients was limited and the clinical profile, as 
well as the geographic location, may in part have 
contributed to the heterogeneity observed in the results. 
In addition, the method of isolation, storage and 
measurement of EVs were not optimal. Yet several 
laboratories have reported that the minimal size cut-off 
for measuring EV by flow cytometry is between 200-
500nm [37]. Since EVs range from 100 nm-1 um in size, it 
is likely that the smaller vesicles were not detectable by 
flow cytometry. Additionally, antigen expression might 
have been too low in certain subsets of the samples, 
which would have prevented accurate measurements. 
 
Technological advances are likely to offer better 
instruments for more accurate measurements in the 
future. In general, protocols used to prepare samples for 
EV analysis are relatively facile and based on differential 
centrifugations [38].  
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The above mentioned studies have demonstrated a direct 
correlation between EV levels and disease severity; it was 
not, however, possible to assess the direct role of EVs in 
malaria pathology based on the above described sets of 
data and further studies are mandatory to fully elucidate 
the role of EVs in malaria.  
 
2.1 The role of EVs in malaria disease 
 
Autopsy studies of brain tissue from patients who died of 
cerebral malaria revealed multifocal capillary obstruction 
by iRBCs, platelets and leukocytes [39]. Malaria is a 
complex disease in which the outcome is determined by a 
combination of several factors. Despite intense research, 
there is still no clear understanding of the mechanisms 
leading to severe disease or death. However, obstruction 
of capillaries and a reduction in perfusion of essential 
organs, as well as leukocyte activation and inflammation, 
are thought to contribute to the disease [40]. An 
exaggerated immune response compromises the integrity 
of the BBB [41] and CM has a high mortality rate of about 
20%, despite treatment [42]. 
 
Infected RBCs sequester in capillaries and cause a 
considerable obstruction in blood flow, thereby 
compromising the perfusion of organs. The sequestration 
is mediated by the interactions of the plasmodial family 
of receptors, i.e., P. falciparum Erythrocyte Membrane 
Protein 1 (PfEMP1) with host receptors expressed on the 
host endothelial cells, such as ICAM1, CD36 and VCAM1 
[43]. During infection, the endothelium is further 
activated and as such, the expression of host receptors 
favouring sequestration of iRBCs is increased. Only 
mature parasites sequester in the capillaries, whereas the 
immature ring stages are found in circulation. Adherence 
protects the parasite from destruction and clearance by 
the spleen as non-adherent mature stages are rapidly 
cleared [44]. Parasites sequester in various organs 
including the heart, lung, brain, liver, kidney, 
subcutaneous tissues and placenta. In addition to the 
accumulation of iRBCs, several histopathological studies 
have demonstrated excessive accumulation of leukocytes 
[45] and platelets [46] in the brain of deceased patients. 
All the vascular cells produce EVs, including monocytes 
[47], RBCs [48], leukocytes [24], platelets and endothelial 
cells [29]. It is therefore highly likely that EVs contribute 
to the pathology by triggering inflammation and 
promoting sequestration of iRBCs to the endothelium. 
 
2.2 The role of platelets as EV producers 
 
In vitro, platelets produce EVs when stimulated by 
calcium ionophores, ADP or thrombin/collagen. The 
platelet-EVs can activate coagulation in vitro and 
participate in thrombus formation in vivo in a model of 
vessel injury through their surface expression of tissue 
factor and phosphatidylserine (PS) [49]. Depending on 
the agonist used to stimulate vesiculation, the amount 
and composition of the EVs will vary and therefore their 
effect on the recipient cells may vary as well, depending 
on the stimulus; for example, after thrombin stimulation 
platelets release EVs enriched in miRNAs [50]. Platelets 
not only contribute to wound healing but also play a role 
in fighting infections, platelet-deficient or aspirin-treated 
mice are more susceptible to death when infected with P. 
chabaudi [51]. Platelets have been found to bind to the 
iRBCs and kill the parasites within post release of PF4 
[52]. Under some circumstances, platelets contribute to 
inflammation, for example, platelet-EVs accumulate in 
the joint fluid of patients with rheumatoid arthritis. There, 
the EVs are pro-inflammatory and can induce the 
secretion of IL-1 from synovial fibroblasts [53]. 
Furthermore, platelets play an important role in the 
induction of the clumping of iRBCs [54] and in vitro 
induce the cytoadherence of iRBCs to endothelial cells 
[55,56]. Interestingly, platelet-EVs bind to iRBCs and 
transfer platelet antigens into the infected cells; binding 
occurs only to iRBCs in a PfEMP1 dependent-manner, 
whereas platelet-EVs do not bind to uninfected RBCs. The 
platelet-EVs dramatically increase the binding of iRBCs to 
the endothelial cells [57]. Therefore, platelet-EVs 
contribute to sequestration and the avoidance of 
clearance of iRBCs by the spleen.  
 
3. Activation of endothelial cells during malaria 
 
Endothelial cells, when stimulated with tumour necrosis 
factor (TNF) or LPS, are able to produce increased 
numbers of EVs, thereby showing the role played by TNF 
in endothelial activation and the capability of cells to 
vesiculate in response to infectious stimuli. Interestingly, 
ex vivo, the endothelial cells from patients with 
complicated malaria are more responsive to TNF-alpha 
stimulation and produce an elevated amount of EVs [58], 
suggesting that some people may be genetically more 
prone to developing severe disease.
 
3.1 Malaria in vivo models and the discovery of EVs  
in severe disease 
 
The first direct evidence for a role of EVs in the 
pathogenesis of severe malaria came from the mouse 
model of CM with P. berghei, using the ATP-binding-
cassette transporter 1 (ABC1) knock-out mice. ABC1 is a 
transporter involved in membrane-lipid turnover and 
promotes Ca2+-induced exposure of PS at the membrane 
surface, an early step in microvesiculation. The ABCA1 
gene is mutated in Tangier disease, a disorder of free 
cholesterol efflux to high density lipoprotein [59]. Hamon 
et al. discovered that the shedding of RBC EVs is reduced 
by about 70% upon ionophores stimulation in the  
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ABC1-/- mice [60]. The ABC1 -/- mice were completely 
resistant to cerebral malaria upon infection with the lethal 
strain P. berghei ANKA. All the ABC1 deficient mice 
survived the neurological phase, whereas 90% of the 
wild-type mice died within the first seven days following 
infection. The immune response was impaired in the 
absence of ABC1 and the mice had a lower plasma level 
of TNF-alpha. These mice also had a weaker up-
regulation of endothelial adhesion molecules in the brain 
micro-vessels, reduced leukocyte sequestration, as well as 
an ablated platelet accumulation. Moreover, the number 
of EVs was found to be dramatically reduced [61]. In 
addition to RBC, platelets and macrophages harbour a 
vesiculation defect upon stimulation by an agonist in vitro. 
Interestingly, the WT and the KO showed comparable 
levels of EVs prior to infection. However, the level of EVs 
increased significantly in the WT at the time of the 
cerebral syndrome, whereas it remained low in the 
ABCA1 KO. After isolation, the EVs from wild-type mice 
were more efficient at inducing clotting and TNF 
production from macrophages than the EVs derived from 
the ABCA1 KO [61]. Similarly, the administration of the 
low-molecular-weight thiol pantethine prevented the 
cerebral syndrome in P. berghei ANKA-infected mice. The 
protection was associated with an impairment on the part 
of the host's response to the infection, in particular, with a 
decrease of circulating EVs and preservation of the blood-
brain barrier integrity without affecting parasite 
development [62]. 
 
3.2 EV activation of innate immunity 
 
The interaction of malaria parasite-derived moieties with 
cells of the immune system is regarded as the initial step 
in the induction of the inflammatory response that 
determines the severity of the disease's condition. Several 
parasite factors are believed to be released during egress 
and to induce a potent pro-inflammatory response. 
Although the exact mechanisms and nature of these 
factors remain unknown, several “malaria toxins” have 
been identified. The Plasmodium 
glycosylphosphatidylinositol (GPI) triggers a potent 
immune response by macrophages and the vascular 
endothelium [63,64]. In addition, the parasite digests 
haemoglobin and the resulting products, the hemozoin 
crystals, are coated with plasmodial DNA that trigger 
TLR9 [65,66]. The AT-rich DNA can induce type I IFNs in 
a TLR-independent fashion [67]. Additional factors are 
likely to contribute to the immune modulation; in fact, 
another study demonstrated that EVs, purified from the 
blood plasma of mice infected by malaria induced potent 
activation of macrophages in a Toll-like receptor 
dependent manner. Immunofluorescence staining 
revealed that EVs contained significant amounts of 
parasite material, indicating that they were derived 
primarily from iRBCs rather than platelets or endothelial 
cells [68]. Furthermore, EVs more potently induced 
macrophage activation than intact iRBCs. Macrophage 
activation by EVs was mediated by a TLR-4- and MyD88-
dependent pathway [68]. A role for iRBC-EVs was further 
confirmed with the isolation of EVs from in vitro cultured 
P. falciparum iRBCs. These studies directly demonstrated 
that EVs originate from iRBCs and infection of the iRBCs 
with P. falciparum increases the secretion of EVs from 
iRBCs by 15 fold when compared with uninfected RBCs 
[69,34]. Proteomic analyses further demonstrated that 
EVs contain malaria specific proteins; most of the 
plasmodial proteins are known to be exported and 
derived mainly from the Maurer’s cleft, which are small 
organelles connected by actin filaments to the RBC 
membrane [70,69]. Interestingly, small vesicles were found 
by electron tomography to be bound to the actin filaments. 
The Maurer’s clefts serve as a platform for the export of 
parasite proteins to the RBC cell surface [71]. Interestingly, 
EVs interact with the innate immune system and are 
rapidly phagocytosed by macrophages, inducing their 
activation and secretion of TNF-alpha [69]. The TNF 
production due to macrophage activation following 
infection is a major source of TNF in vivo [72]. There is a 
positive correlation between TNF level and EVs found in 
the plasma of patients with malaria [73]. In conclusion, 
these data indicate that iRBC EVs are highly likely to 
contribute to the inflammation observed in severe malaria 
and might therefore be a novel target for the development 
of therapies to prevent severe disease (Figure 1).  
 
4. RBC-derived EVs in cell-to-cell communication 
 
In addition to the contribution of EVs from different cell 
sources to malaria pathology, recent evidence indicates 
that EVs derived from P. falciparum iRBCs can regulate 
parasite density and mediate horizontal transfer of 
nucleic acids to regulate the rate of conversion into 
gametocytes, i.e., the transmission stage. To determine 
whether iRBCs communicate and transfer information, 
Regev-Rudzki and colleagues used two strains expressing 
different drug resistance cassettes, which were linked to 
different fluorescent markers expressing red or green 
fluorescence. When the two transgenic strains (one 
containing a blasticidin (BSD) resistance marker and the 
other a WR resistance marker) were co-cultured in vitro, 
the parasites initially died. However, five days post initial 
drug treatment, recrudescence occurred and the 
surviving parasites contained both the green and red 
fluorescent markers, demonstrating the transfer of 
plasmids between the two transgenic strains. Using a 
trans-well membrane system it was subsequently shown 
that the transfer of drug resistance is not dependent on 
cell to cell contact, but instead depends on soluble factors 
from iRBCs smaller than 400 nm [74]. The transfer is 
inhibited by cytochalasin D, an inhibitor of actin 
polymerization and oryzalin [75]. Finally, the transfer of 
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DNA was demonstrated by using in vitro purified EVs. 
Vesicles could be observed budding at the surface of the 
iRBCs by atomic force microscopy (AFM) [74]. 
Quantification of vesicles by Nanosight in supernatants 
of synchronized parasite culture indicated that most 
EVs were released during the late stages and the size of 
the vesicles varied from 50-250 nm [69]. The vesicular 
shape, size and lipid bilayer were further confirmed by 
electron microscopy and cryo-electron microscopy. 
Fluorescent-labelled EVs were internalized by iRBCs 
and targeted towards the nucleus, and accordingly, the 
transferred plasmid DNA was localized in the nuclear 
periphery, thereby suggesting that EV cargo might 
target gene regulation in the recipient cell. Furthermore, 
in vitro analyses have shown that iRBC EVs induce 
sexual stage conversion in cultured parasites in a dose 
dependent manner. Highly elevated levels of 
gametocytes were found in cultures where EVs had 
been introduced [69,74].  
 
The Maurer’s clefts are important for the production of 
EVs and the PTP2 knock-out parasites produce less 
EVs as measured by AFM. PTP2 is expressed on 
budding vesicles from the Maurer’s clefts and is 
essential for PfEMP1 export to the host cell membrane 
[76]. Interestingly, the PTP2 KO parasites were also 
defective in the uptake of MVs, since transfer of the 
BSD gene was not possible using this strain. The 
localization of PTP2 on vesicles budding from the 
Maurer’s clefts suggests that EVs may rather be 
derived from the Maurer’s clefts rather than from the 
host cell membrane, illuminating the possibility that 
different kinds of vesicles with diverse functions are 
released by iRBCs (Figure 2). 
 
 
Figure 2. P falciparum infected RBCs (donor cells) secrete EVs 
that are subsequently taken up by another iRBC (recipient cell). 
EVs act as a quorum sensing-like mechanism by inducing 
differentiation towards gametocytes. The stimuli that trigger EV 
release from the donor cell, as well as the mechanisms of uptake 
by the recipient cells are still unknown.. However, the Maurer’s 
clefts seem to play a role particularly in the protein PTP2. The 
molecular mechanisms of differentiation are unknown; however, 
EVs contain several factors such as DNA, mRNA, miRNA, 
proteins and lipids that can potentially be involved. 
5. Quorum sensing-like mechanisms  
in Plasmodium infections 
 
Since iRBC-derived EVs are able to transfer nucleic acids 
from parasite to parasite and to induce differentiation to 
gametocytes, they have been proposed to exhibit quorum 
sensing-like mechanisms. Previous investigations into 
bacteria have shown that prokaryotes use signalling 
molecules to control traits such as antibiotic production, 
nutrient storage, sporulation, biofilm formation and 
virulence factor secretion. This phenomenon, which was 
initially discovered in bacteria, has been termed 'quorum 
sensing' and in general refers to activities using signalling 
molecules to synchronize activities among large 
populations of cells. 
 
Some basic principles can be distinguished in QS according 
to Rutherford et al.; in the first stage, the bacteria produce 
the signalling quorum-sensing molecules. While at low cell 
density, the molecules diffuse without reaching the 
threshold required for detection. As the cell density 
increases, the cumulative production of molecules leads to 
a local high concentration sufficient for reaching the 
threshold necessary for detection and response. Finally, 
after detection by specific receptors in the cells and 
activation of the expression of genes necessary for the 
cooperative behaviours, the QS molecules induce the 
release of more QS molecules. This positive feedback 
mechanism of induction further increases bacterial 
synchronicity [77]. The success of infection depends on the 
ability of the parasite to survive in its mammalian host and 
to ensure transmission to future hosts. Overgrowth can 
damage the host and thereby limit the parasites
transmission potential [78]. The quorum-sensing mechanism 
has been observed in vector-borne parasites such as 
Trypanosoma brucei, which is the causative agent of African 
sleeping sickness. The parasites differentiate from replicating 
slender bloodstream forms to non-dividing stumpy forms, 
thereby limiting the parasite's population size and allowing 
survival of the mammalian host and establishment of a 
stable host-parasite relationship [79]. In the protozoan 
parasite T. brucei, a density-sensing mechanism activates 
the differentiation of proliferative slender cells to stumpy 
forms through the release of stumpy induction factor (STI) 
[80,81,82]. It would be a major advantage for parasites such 
as P. falciparum to communicate during blood-stage infection 
in order to enable populations to react to changing 
conditions in the host and to regulate cell density [83]. 
 
In conclusion, EVs constitute a potential target for the 
control and management of severe P. falciparum infections; 
it also poses as a target for novel transmission blocking 
strategies of this important human pathogen. It is a major 
advantage for P. falciparum to communicate during the 
blood-stage infection in order to enable parasites at the 
population level to react to changing conditions in the host.  
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6. The involvement of EVs in gametocyte induction  
 
Although EVs can serve as vehicles for transferring 
plasmid DNA from parasite to parasite, the real factor 
responsible for cell-cell communication and the induction 
of gametocytes is yet to be identified. Several studies in 
other systems have pointed out a role for lipids, proteins, 
DNA and RNA in transfer of information mediated by 
EVs. For example, EVs may contain different forms of 
DNA, genomic DNA fragments [84] [85], mtDNA [86] 
ssDNA and cDNA retrotransposon [87]. It has been 
shown that gDNA can be transported by EVs and 
increase the gDNA-coding mRNA and protein expression 
in the recipient cells [84]. For example, the BCR/ABL 
hybrid gene was transferred from K562 EVs to normal 
neutrophils and localized close to the nucleus, as 
demonstrated by DNA-FISH, thereby suggesting that 
tumours can transfer genetic mutations from cell to cell as 
a new avenue for expanding tumours [84].  
 
EVs can mediate the transfer of functional 
transmembrane proteins and proteases from the donor to 
the target cell. In the context of a tumour, the 
glioblastoma cells can share the oncogenic receptor 
EGFRvIII through EVs, thereby favouring tumour growth 
[88] [89] by providing a functional receptor on the target 
cells. The EV-derived from a tumour can transfer the 
oncogenic receptor tyrosine kinase MET to bone marrow-
derived cells to promote their education, mobilization 
and pro-invasive behaviour [90]. Active Wnt is secreted 
in exosomes during Drosophila development and in 
human cells [91] also Wnt11 secreted in fibroblast EVs 
drive breast cancer cell invasive behaviour [92]. Some 
pathogens use EVs secretion to their own advantage to 
favour their growth and evade the immune system. 
 
GP63, a Zn-metallo-protease secreted in EVs by 
Leishmania donovani, targets pre-miRNA processor Dicer1 
to prevent miRNP formation in L. donovani interacting 
hepatic cells, thereby shutting down the lipid metabolism 
and promoting parasite growth [93]. The CCR5 
chemokine receptors are transported on EVs and transfer 
of CCR5+ EVs by PBMCs to CCR5- PBMCs render the 
CCR5- cells susceptible to HIV infection [94]. 
 
Additionally, EVs contain mRNA and miRNA that can be 
transferred to recipient cells and regulate gene 
transcription in the recipient cell [10]. The RNA profile of 
EVs is different than the RNA profile of the source cells 
and EVs seem to lack ribosomal RNA, while being 
enriched in small RNA [95]. The role of miRNA has been 
studied in a different context. The EVs can transfer 
miRNA between T cells and dendritic cells (DC) at the 
immunological synapse [96]. DCs release EVs that 
contains miRNA. Upon maturation of the DCs, the 
miRNA profile varies [97], regulating the transcription of 
genes in the target DCs; therefore, immature DC-EVs 
have a different function than mature DC-EVs. Epstein 
Barr viruses infect B cells and functional mature EBV-
encoded miRNAs are secreted in EVs by EBV-infected B 
cells and mediate repression of CXCL11/ITAC, an 
immunoregulatory gene down-regulated in primary 
EBV-associated lymphomas in recipient immature 
monocyte-derived dendritic cells [98].  
 
Platelets have been shown to contain an abundant and 
diverse array of microRNAs and platelet-derived MVs 
are the most abundant EVs in the blood circulation. Upon 
activation, platelets release EVs containing functional 
Ago2:miR223 complexes [99], which can induce 
apoptosis after internalization by recipient cells 
(HUVEC) by down-regulating the expression of the 
insulin-like growth factor 1 receptor [50]. EVs secreted 
by myotubes play a role in myogenesis by transferring 
miRNA and down-regulating Sirtuin1 in myoblasts 
[100]. Interestingly the proteomics analysis of iRBC-EVs 
revealed the presence of human Argonaute 2 as a 
component of iRBC EVs. Furthermore, RNA can be 
isolated from EVs and is mainly composed of small RNA, 
as shown by Bioanalyzer analyses, thus raising the 
possibility that EVs contain functional RISC complexes 
that could be transferred to the recipient cell in order to 
regulate gene transcription. Interestingly, it has recently 
been shown that RBC miRNA can regulate that 
gametocytaemia. La Monte and colleagues provided 
evidence for the presence of miRNA in HbSS and HbSA 
in patients with sickle cell anaemia, regulates gametocyte 
differentiation [101]. Intriguingly, at a similar level as that 
seen by Mantel et al., where EVs from P falciparum iRBCs 
were shown to have an important role in parasite density 
regulation [69]. It has been shown that EVs from iRBCs 
contain small RNAs, suggesting a similar function as that 
seen in patients with sickle cell traits. The presence of 
functional miRNAs in EVs has also been found in other 
systems [98,99]. Although plasmodium is not thought to 
possess the machinery for RNAi pathway [102], it has been 
demonstrated that host miRNAs regulate gametocytaemia. 
 
A strong link between the transcription factor APapi2 and 
sexual stage conversion has been indicated [103]. It would be 
highly interesting to try and identify the links between EVs 
and epigenetic factors that influence gametocytogenesis. 
Investigating the content of EVs in terms of lipids, DNA, 
RNA and proteins will likely reveal the molecular pathways 
involved in the quorum sensing-like mechanisms in parasite 




With escalating evidence that the role of EVs are highly 
influential in malaria biology, it has become clear that 
investigations concerning synthesis, mechanisms of 
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uptake, content, as well as their direct role in 
transmission are highly important as part of an incentive 
for understanding malaria biology. The recently 
discovered link between EVs and malaria sexual stage 
switching holds promising potential for solving the long-
standing problem of hindering malaria transmission and 
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